Company
Alesta Therapeutics
A biotech company developing novel oral small molecule therapies for underserved rare diseases.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Leiden, The Netherlands
- alestatherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our globally experienced team brings together diverse expertise to drive small molecule innovation, developing targeted and effective therapies for rare diseases where few options exist. With a patient-friendly approach, we prioritize safety, efficacy, and accessibility. Ensuring every step of development reflects both scientific excellence and patient trust.
Funding snapshot
- Latest round
- Series A2025-01-08
Funding rounds
- Series A
- 2025-01-08
Loading relationship preview